Direct interaction of salicylaldehyde oxyanion with ethyl 7-chloro-8-nitro-4-oxoquinoline-3-carboxylate (2) delivered the respective 7-(2-formyl-phenoxy)-8-nitro-4-oxoquinoline-3-carboxylic ester 3. Reductive cyclization of 3 furnished the corresponding 4-oxo-[1,4]benzoxazepino[2,3-h]quinoline-3-carboxylic ester 5. Acid-catalyzed hydrolysis of the esters 3/5 produced the respective acids 4/6. Structural assignments for the new compounds 3 -6 are supported by microanalytical and spectral (IR, HRMS, NMR) data and confirmed by X-ray structure determination for compound 5. Interestingly, compound 6 exhibited good antifungal activity against C. albicans.
Introduction
Synthetic fluoroquinolones (e. g. ciprofloxacin [2 -5] Fig. 1 ) represent a successful achievement towards the design and development of potent antiinfectious drugs [2 -12] . On the other hand, the tricyclic dibenz (Cyperaceae), an herbaceous plant growing in the Mediterranean area. The latter compounds have been shown to possess antioxidant activity [13] (radical scavengers), while several other related species were prepared and patented as useful agents for the treatment and prevention of AIDS [14] . It is noteworthy that some [1, 4] benzoxazepinone derivatives were reported to inhibit HIV-1 replication by interacting with the NNRTI binding pocket [15] . Furthermore, several members of the [1, 4] benzoxazepinone class have been reported as monoanionic inhibitors of squalene syn-thetase in HMG-CoA reductase regulation [16] and as y-secretase inhibitors for the treatment of Alzheimer's disease [17] , whereas 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[bf ] [1, 4] oxazepine (loxapine, Fig. 1 ) is an effective antipsychotic drug [18, 19] .
Herein, we wish to report on the synthesis of the new tetracyclic system 5/6 incorporating a 4-oxopyridine entity condensed to dibenz[bf ] [1, 4] oxazepine as depicted in Scheme 1. As a structural feature, the heterocyclic assembly in 5/6 encompasses fluoroquinolone (rings A, B) and dibenz [1, 4] oxazepine (rings B, C, D) chemotypes. Such new hybrid heterocyclics, exemplified by 6, might display interesting bioproperties.
Results and Discussion

Synthesis
A feasible two-step synthetic route towards the target compound 6 was devised as depicted in Scheme 1. This approach is based upon annelation of the 1,4-benzoxazepine (rings C, D of compound 6) onto the appropriately substituted 4-oxoquinoline system (rings A, B). The first step involves direct interaction between the salicyladehyde oxyanion and the 4-oxoquinoline-3-carboxylate 2 with ultimate displacement of the C(7)-chloride ion and consequent formation of the 7-(2-formylphenoxy)-8-nitro-4-oxoquinoline 3. This nucleophilic aromatic substitution (S N (Ar)) reaction, conducted at 60 -65 • C, is facilitated by the presence of the neighboring electronwithdrawing 6-fluoro, 8-nitro and 4-keto entities. Related 6-fluoro-4-oxo-7-(substituted)phenoxyquinoline-3-carboxylic acids have recently been prepared in an analogous manner and evaluated as potential antitrypanosomal and antibacterial agents [20] .
The second step involves reductive cyclization of compound 3 using SnCl 2 /conc. HCl, and is initiated by the in situ generation of the 8-amino species 3A (Scheme 1). This latter intermediate underwent spontaneous intramolecular cyclization involving the electrophilic formyl carbon (of ring B) and the suitably located nucleophilic amino group with ultimate construction of ring C in producing the [1, 4] benzoxazepino[2,3-h]quinoline-3-carboxylate 5. Acid-catalyzed hydrolysis of the latter ester furnished the corresponding carboxylic acid 6 as the target product. In this context, it is worth noting that com- Table 2 . Selected bond lengths (Å) and angles (deg.) for 5.
Bond lengths
Bond angles (15) 1.199 (4) pound 8 represents the first dibenz ,4] oxazepine that was prepared by selective reduction of the appropriate nitro-aldehyde 7 to the respective aminoaldehyde 7A which underwent spontaneous cyclization to give directly the desired Schiff base 8, albeit in poor yield [21] (Scheme 2). Recent reinvestigation of this method has led to an improvement of the etherification procedure [22] . On the other hand, interaction of ofluorobenzaldehyde with o-aminophenol, proceeding via initial imine formation followed by etherification (Scheme 3), represents an alternative one-pot synthesis of dibenz[b, f ][1,4]oxazepine (9) [23] .
Spectral properties
The IR, MS and NMR spectral and the microanalysis data for the new compounds 3 -6 are in accordance with the assigned structures; details are given in the Experimental Section. Thus, the mass spectra display the correct molecular ion peaks for which the measured high resolution (HRMS) data are in good agreement with the calculated values. DEPT and 2D (COSY, HMQC, HMBC) experiments showed correlations that helped in the 1 H and 13 C signal assignments to the different carbons and the attached/neighboring hydrogens in compounds 3 -6. In the 13 C NMR spectra of 5 and 6, the skeletal carbons of the benzo-fused entity (C-4, C4a, C-5, C-6, C-6a) resonate as doublets due to scalar spin-spin coupling with the fluorine atom at C-6. Likewise, the skeletal carbons of ring B in compounds 3 and 4 are recognizable by their doublet signals originating from scalar (through bond) coupling with the nearby fluorine atom. For compounds 5 and 6, distinct "three-bond" ( 1 H, 13 C) correlations are observed between 5-H and each of C-4, C-6a and C-13b, between 2-H and each of C-4, C-13b and CO 2 R, between 1 H and each of C-2 and C-13b, between 9-H/11-H and C7a, between 8-H/10-H and C-11a, as well as between 12-H and each of C-7a and C-13a.
Molecular structure of 5
A crystal structure determination was performed to confirm the structure of 5 (and by inference that of 6). A summary of data collection and refinement parameters is given in Table 1 , while selected bond lengths and angles are provided in Table 2 . The molecular structure of 5 in the crystal is displayed in Fig. 2 . The three sixmembered aromatic rings (A, B, D) in the molecular structure of 5 are planar and the dihedral angle between the plane containing the atoms N1-C2-C3-C4-C4A-C13B and the adjacent one containing atoms C6A-C13A-C4A-C5-C6-C13B-C4A is only 5.7(1) • . The dihedral angle between the two rings (B, D) spanning the seven-membered ring (C), namely C6A-C13A-C4A-C5-C6-C13B-C4A and C10-C11-C11A-C7A-C8-C9, is 44.0(1) • . As expected, the seven-membered ring is not planar with the dihedral angle between the fraction O7-C7A-C11A-C12 and the fraction O7-C6A-C13A-N13 being 57.7(1) • .
Preliminary pharmacological screening
Preliminary screening tests have indicated that compound 6 exhibit good activity against Candida Albicans clinical isolates, yet display moderate potency against Eschericia coli and Staphylococcus aureus. The preparation of several analogs of 6, decorated with various substituents appended to ring D, for assessment of their biological properties is currently underway.
Experimental Section
The following chemicals, used in this study, were purchased from Acros and were used as received: 2,4-dichloro-5-fluoro-3-nitrobenzoic acid, ethyl 3-(N,Ndimethylamino)acrylate, cyclopropylamine, and salicylaldehyde. Melting points were determined on a Gallenkamp electrothermal melting apparatus in open capillary tubes. IR spectra were recorded as KBr discs on a Nicolet Impact-400 FT-IR spectrometer. Elemental analyses were performed on a Euro Vector elemental analyzer model EA 3000. 1 H and 13 C NMR spectra were recorded on a 500 MHz spectrometer (Bruker DPX-500) with TMS as the internal standard. Chemical shifts are expressed in δ units; J values for 1 H-1 H, 1 H-19 F and 13 C- 19 F coupling constants are given in Hertz. Highresolution mass spectra (HRMS) were acquired (in positive mode) using the electrospray ion trap (ESI) technique by collision-induced dissociation on a Bruker APEX-4 (7 Tesla) instrument. The samples were dissolved in acetonitrile, diluted in spray solution (methanol-water 1 : 1 v/v + 0.1 formic acid) and infused using a syringe pump with a flow rate of 2 µL min −1 . External calibration was conducted using arginine cluster in a mass range m/z = 175 -871.
Ethyl 7-chloro-1-cyclopropyl-6-fluoro-8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate (2)
This compound, required as starting material, was prepared from 2,4-dichloro-5-fluoro-3-nitrobenzoic acid, ethyl 3-(N,N-dimethylamino)acrylate, and cyclopropylamine, according to literature procedures [24 -27] .
Ethyl 1-cyclopropyl-6-fluoro-7-(2-formylphenoxy)-8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate (3)
To a stirred solution of compound 2 (1.1 g, 3 mmol) in DMF (20 mL) was added a freshly prepared solution of salicyldehyde (0.48 g, 4 mmol) in aqueous sodium hydroxide (0.16 g, 4 mmol), and the resulting mixture was heated at 60 -65 • C for 4 -5 h. Thereafter, the reaction mixture was cooled and poured onto ice water (100 mL); the precipitated product was collected by suction filtration, washed with water (3 × 10 mL), dried and recrystallized from ethanol. Yield: 1. 
1-Cyclopropyl-6-fluoro-7-(2-formylphenoxy)-8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (4)
A suspension of the ethyl ester 3 (0.5 g, 1.15 mmol) in 30 mL of 6 N aq. HCl was refluxed (oil bath 110 o C) for 48 h. Thereafter, the reaction mixture was cooled and poured onto ice water (30 mL); the precipitated product was collected by suction filtration, washed with water (3 × 
Ethyl 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo[1,4]benzoxazepino[2,3-h]quinoline-3-carboxylate (5)
Anhydrous stannous chloride (1.25 g, 6.6 mmol ) was added portionwise to a vigorously stirred and cooled (0 to 4 • C) solution of the ester 3 (4 mmol) in conc. HCl (10 mL). The reaction mixture was further stirred for additional 12 -15 h at r. t. Thereafter, the solution was diluted with ice water (100 mL) and treated portionwise with a cold aqueous solution of sodium hydroxide (40 %, 25 mL) to pH ∼14. The resulting yellowish precipitate was collected by suction filtration, washed with water (4 × 10 mL), and dried 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo [1, 4] benzoxazepino [2,3-h] quinoline-3-carboxylic acid (6) A suspension of the ethyl ester 5 (1.57 g, 4 mmol) in 30 mL of 6 N aq. HCl was refluxed (oil bath 110 • C) for 48 h. Thereafter, the reaction mixture was cooled and poured onto ice water (100 mL); the precipitated product was collected by suction filtration, washed with water (3 × 10 mL), dried and recrystallized from ethanol. Yield: 1. 3 , cut from a longer slightly yellowish crystal, was epoxymounted on a glass fiber. The data were collected at room temperature employing MoK α radiation using a Calibur/Oxford diffractometer equipped with an Eos CCD detector. CRYSALIS PRO soft-ware was used for data collection, absorption correction and data reduction [28] . Three sets of ω scans were collected yielding 167 frames. Average exposure time was 65.8 s per frame. A one-degree scan width was used and the detector to crystal distance was 45 mm. A multi-scan absorption correction was applied with minimum and maximum transmission factors of 0.815 and 1.000, respectively. Cell parameters were refined using all observed reflections. The structure was solved by Direct Methods using OLEX 2 [29] and refined by full-matrix least-squares on F 2 . Refinement was done using the SHELXTL program package [30, 31] . The terminal methyl group C19 of the ethyl ester group was found disordered and modeled over two positions with 0.67 and 0.33 occupancy, respectively. All nonhydrogen atoms were refined anisotropically with the hydrogen atoms placed constrained and assigned isotropic thermal parameters of 1.2 times that of the riding atoms. Molecular graphics and publication material were prepared using SHELXTL [30] .
CCDC 882392 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data request/cif.
